ARTICLE | Financial News
BostonGene raises $50M series A to develop personalized cancer therapy software
April 25, 2019 10:49 PM UTC
BostonGene will deploy its $50 million series A funds to scale and develop its cloud-based platform for determining optimal patient-specific cancer therapies.
NEC Corp. is the sole investor in the untranched financing announced on Wednesday. ...